Brez internetne povezave — prikazana je shranjena različica strani.

Kala Pharmaceutic…

USUSD
← Na Filter Delnic

Kala Pharmaceuticals Inc (US:KALA) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
kalarx.com
Odnosi z Vlagatelji
kalarx.com/investors/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
Waltham, United States
Izvršni Direktor
Avi Minkowitz
Zaposleni
6
Ustanovljena
2009
Delnice v Obtoku
19.34 mio. na dan 2026-08-14
Prosto Prenosljive Delnice
19.34 mio.
Tržna Kapitalizacija
5.68 mio. USD
Notranje Osebe
1.24%
Institucionalni Vlagatelji
4.07%
Panoga (SIC)
Pharmaceutical Preparations
P/E
izguba
FCF
—
Dolg
26.9 mio. USD
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
0.47 USD · P/NAV 0.56
Balance sheet date30.06.2026
Assets10.6 mio. USD
− Liabilities1.54 mio. USD
= NAV (lastniški delež delničarjev podjetja)9.04 mio. USD
= Tangible NAV9.04 mio. USD
Delnice19 339 786
NAV per share0.47 USD
Otipljiv NAV na Delnico0.47 USD
Share price (KALA)0.2600 USD
P/NAV0.56
NAV history
Balance sheet dateNAVNAV per share
30.06.20269.04 mio. USD0.47 USD
31.03.202610.8 mio. USD0.58 USD
31.12.20257.00 mio. USD12.56 USD
30.09.2025−8.67 mio. USD−1.17 USD
30.06.2025−3.21 mio. USD−0.48 USD
31.03.20255.71 mio. USD0.88 USD
31.12.202412.3 mio. USD2.02 USD
30.09.20246.86 mio. USD1.49 USD
Opis

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksKALA glavnaUSD0.26 -7.14%navadne delnice
LSE London Stock Exchange0JQ2 IOBUSD0.5145 +0.00%navadne delnice

Cena v 3 Mesecih

dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Vanguard Capital Managem…1.14%220 6232026-06-30
VANGUARD INDEX FUNDS-Van…1.14%220 6232026-06-30
Geode Capital Management…0.75%145 1522026-06-30
IWICKI MARK T. (Director…≈0.54%103 5402025-10-23
Vanguard Fiduciary Trust…0.52%101 3962026-06-30
Fidelity Concord Street…0.5%96 4922026-07-31
State Street Corporation0.46%88 5702026-06-30
Blackrock Inc.0.37%71 5422026-06-30
Northern Trust Corporati…0.22%41 6062026-06-30
KHARABI DARIUS (Officer)≈0.22%41 7602025-10-22
BRAZZELL ROMULUS KIM (Of…≈0.19%35 9522025-10-22
BAZEMORE TODD M (Directo…≈0.19%35 9332025-10-22
REUMUTH MARY (Chief Fina…≈0.15%28 9062025-10-23
Fidelity Concord Street…0.1%19 1972026-07-31
Fidelity Concord Street…0.09%17 3972026-07-31
KOVEN ANDREW IAN (Direct…≈0.09%16 9722025-06-13
ROSEN HOWARD B (Director…≈0.09%16 5022025-06-13
Fidelity Concord Street…0.07%12 8322026-07-31
PERRY GREGORY D (Directo…≈0.07%13 3442025-06-13
Qube Research & Technolo…0.06%11 0732026-06-30
Goldman Sachs Group Inc0.06%10 9212026-06-30
MYERS CHARLES DANIEL (Di…≈0.05%10 3742025-06-13
UBS Group AG0.05%9 0572026-06-30
Tower Research Capital L…0%6162026-06-30
John Hancock Variable In…0%3552026-06-30
BAKER BROS ADVISORS, L.P…——2025-10-01